+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemostats Market By Type, By Formulation, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 237 Pages
  • June 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671099
The global hemostats market was valued at $2,805.93 million in 2021 and is projected to reach $4,712.2 million by 2031 registering a CAGR of 5.3% from 2021 to 2031.

Hemostats are materials or products that when placed on a bleeding site during surgery stop the bleeding by the bloods clotting function. Hemostat are used in many surgical procedures to control bleeding on tissue or organ. They stop both internal and external major or minor bleeding due to injuries, cuts, tearing, ruptures, dental operations, and surgical or spontaneous interventions. Different types of hemostats are available in the market such as thrombin-based hemostats, collagen-based hemostats, gelatin-based hemostats, and cellulose-based hemostats. Hemostats are designed to clamp small blood vessels for hemorrhage control. As a result, they are widely employed in surgical centers, hospitals, and nursing positions. They are available in various sizes, materials, and compositions and used in surgeries and trauma cases.

The major factors that foster the growth of the global hemostats market are surge in number of surgical procedures and availability of medical specialties for the treatment and management of several diseases. In addition, rise in number of cardiac surgeries & orthopedic surgeries and surge in number of injuries and accidents boost the growth of the hemostats market. Moreover, technologically advancements in products having rapid effects are expected to propel the demand for hemostats during the forecast period.

For instance, in February 2021, EndoClot Plus Inc. announced that it received an FDA approval for EndoClot Polysaccharide Hemostatic System. This innovative product helps gastroenterologists to prevent bleeding rapidly. This technology represents a significant milestone in advancing the care of gastrointestinal problems. In addition, in March 2020, the Institute of Nano Science and Technology, under the Department of Science & Technology, developed a starch-based hemostat material. This material helps in stopping the blood flow by concentrating the natural clotting factors in the blood. Thus, the aforementioned factors are anticipated to drive the growth of the hemostat market.

As per the estimates published by the National Center for Biotechnology Information (NCBI), about 60-70% of all transfused red blood cells are utilized in a surgical setting, as bleeding during surgeries is one the most feared complications to occur in these procedures and hemostats reduce that complications of bleeding during surgical procedure. This has led to substantial demand for hemostat product offerings in the global market.

However, clinical limitations with certain products severely hamper the growth of the market. In contrast, increase in number of number of hospitals and surgical centers in both developed and emerging countries is expected to offer lucrative growth opportunities for players in the hemostats market.

The global hemostats market is segmented into type, formulation, application, and region to provide a detailed assessment of the market. By type, the market is segregated into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelation-based hemostats, collagen-based hemostats, and others. On the basis of formulation, it is categorized into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, powder hemostats, and others. Depending on application, it is fragmented into orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other surgeries.

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global hemostats market are Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Hemostatis LLC, Integra Life Sciences Corporation, Johnson & Johnson, Medtronic Plc, Pfizer Inc., Stryker Corporation, and Teleflex Incorporated.
Key benefits for stakeholders
  • The study provides an in-depth analysis of the global hemostats market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2021 to 2031 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and types of hemostats used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Key Market Segments

By Type

  • Thrombin Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats
  • Others

By Formulation

  • Sheet and Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats
  • Others
  • Matrix and Gel Hemostats

By Application

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Baxter International Inc.
  • B.Braun Melsungen AG
  • Becton Dickinson and Company
  • Hemostatis LLC
  • Integra Life Sciences Holding Corporation
  • Johnson and Johnson
  • Medtronic Plc
  • Pfizer Inc.
  • Stryker Corporation
  • Teleflex Incorporated

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: HEMOSTATS MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Thrombin Based Hemostats
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Oxidized Regenerated Cellulose Based Hemostats
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Combination Hemostats
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Gelatin Based Hemostats
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Collagen Based Hemostats
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: HEMOSTATS MARKET, BY FORMULATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Matrix and Gel Hemostats
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Sheet and Pad Hemostats
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Sponge Hemostats
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Powder Hemostats
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Others
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: HEMOSTATS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Orthopedic Surgery
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 General Surgery
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Neurological Surgery
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Cardiovascular Surgery
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Reconstructive Surgery
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
6.7 Gynecological Surgery
6.7.1 Key market trends, growth factors and opportunities
6.7.2 Market size and forecast, by region
6.7.3 Market analysis by country
6.8 Others
6.8.1 Key market trends, growth factors and opportunities
6.8.2 Market size and forecast, by region
6.8.3 Market analysis by country
CHAPTER 7: HEMOSTATS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Formulation
7.2.4 North America Market size and forecast, by Application
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Formulation
7.2.5.1.3 Market size and forecast, by Application
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Formulation
7.2.5.2.3 Market size and forecast, by Application
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Formulation
7.2.5.3.3 Market size and forecast, by Application
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Formulation
7.3.4 Europe Market size and forecast, by Application
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Formulation
7.3.5.1.3 Market size and forecast, by Application
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Formulation
7.3.5.2.3 Market size and forecast, by Application
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Formulation
7.3.5.3.3 Market size and forecast, by Application
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Formulation
7.3.5.4.3 Market size and forecast, by Application
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Formulation
7.3.5.5.3 Market size and forecast, by Application
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Formulation
7.3.5.6.3 Market size and forecast, by Application
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Formulation
7.4.4 Asia-Pacific Market size and forecast, by Application
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Formulation
7.4.5.1.3 Market size and forecast, by Application
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Formulation
7.4.5.2.3 Market size and forecast, by Application
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Formulation
7.4.5.3.3 Market size and forecast, by Application
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Formulation
7.4.5.4.3 Market size and forecast, by Application
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Formulation
7.4.5.5.3 Market size and forecast, by Application
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Formulation
7.4.5.6.3 Market size and forecast, by Application
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Formulation
7.5.4 LAMEA Market size and forecast, by Application
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Formulation
7.5.5.1.3 Market size and forecast, by Application
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Formulation
7.5.5.2.3 Market size and forecast, by Application
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Formulation
7.5.5.3.3 Market size and forecast, by Application
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Formulation
7.5.5.4.3 Market size and forecast, by Application
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Baxter International Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 B.Braun Melsungen AG
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Becton Dickinson and Company
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Hemostatis LLC
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Integra Life Sciences Holding Corporation
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Johnson and Johnson
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Medtronic Plc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Pfizer Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Stryker Corporation
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Teleflex Incorporated
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 2. Electrostatic Discharge (Esd) Packaging Market Revenue, for Bags, by Region , 2021-2030,($Million)
Table 3. Electrostatic Discharge (Esd) Packaging Market for Bags by Country, 2021-2030,($Million)
Table 4. Electrostatic Discharge (Esd) Packaging Market Revenue, for Trays, by Region , 2021-2030,($Million)
Table 5. Electrostatic Discharge (Esd) Packaging Market for Trays by Country, 2021-2030,($Million)
Table 6. Electrostatic Discharge (Esd) Packaging Market Revenue, for Boxes & Containers, by Region , 2021-2030,($Million)
Table 7. Electrostatic Discharge (Esd) Packaging Market for Boxes & Containers by Country, 2021-2030,($Million)
Table 8. Electrostatic Discharge (Esd) Packaging Market Revenue, for Esd Foam, by Region , 2021-2030,($Million)
Table 9. Electrostatic Discharge (Esd) Packaging Market for Esd Foam by Country, 2021-2030,($Million)
Table 10. Electrostatic Discharge (Esd) Packaging Market Revenue, for Esd Films, by Region , 2021-2030,($Million)
Table 11. Electrostatic Discharge (Esd) Packaging Market for Esd Films by Country, 2021-2030,($Million)
Table 12. Electrostatic Discharge (Esd) Packaging Market Revenue, for Others, by Region , 2021-2030,($Million)
Table 13. Electrostatic Discharge (Esd) Packaging Market for Others by Country, 2021-2030,($Million)
Table 14. Global Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 15. Electrostatic Discharge (Esd) Packaging Market Revenue, for Network and Telecommunication Industry, by Region , 2021-2030,($Million)
Table 16. Electrostatic Discharge (Esd) Packaging Market for Network and Telecommunication Industry by Country, 2021-2030,($Million)
Table 17. Electrostatic Discharge (Esd) Packaging Market Revenue, for Consumer Electronics & Computer Peripheral, by Region , 2021-2030,($Million)
Table 18. Electrostatic Discharge (Esd) Packaging Market for Consumer Electronics & Computer Peripheral by Country, 2021-2030,($Million)
Table 19. Electrostatic Discharge (Esd) Packaging Market Revenue, for Automotive Industry, by Region , 2021-2030,($Million)
Table 20. Electrostatic Discharge (Esd) Packaging Market for Automotive Industry by Country, 2021-2030,($Million)
Table 21. Electrostatic Discharge (Esd) Packaging Market Revenue, for Military and Defense, by Region , 2021-2030,($Million)
Table 22. Electrostatic Discharge (Esd) Packaging Market for Military and Defense by Country, 2021-2030,($Million)
Table 23. Electrostatic Discharge (Esd) Packaging Market Revenue, for Healthcare, by Region , 2021-2030,($Million)
Table 24. Electrostatic Discharge (Esd) Packaging Market for Healthcare by Country, 2021-2030,($Million)
Table 25. Electrostatic Discharge (Esd) Packaging Market Revenue, for Aerospace, by Region , 2021-2030,($Million)
Table 26. Electrostatic Discharge (Esd) Packaging Market for Aerospace by Country, 2021-2030,($Million)
Table 27. Electrostatic Discharge (Esd) Packaging Market Revenue, for Others, by Region , 2021-2030,($Million)
Table 28. Electrostatic Discharge (Esd) Packaging Market for Others by Country, 2021-2030,($Million)
Table 29. Electrostatic Discharge (Esd) Packaging Market, by Region, 2021-2030,($Million)
Table 30. North America Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 31. North America Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 32. North America Electrostatic Discharge (Esd) Packaging Market, by Country, 2021-2030,($Million)
Table 33. U.S. Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 34. U.S. Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 35. Canada Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 36. Canada Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 37. Mexico Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 38. Mexico Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 39. Europe Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 40. Europe Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 41. Europe Electrostatic Discharge (Esd) Packaging Market, by Country, 2021-2030,($Million)
Table 42. Germany Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 43. Germany Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 44. United Kingdom Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 45. United Kingdom Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 46. France Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 47. France Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 48. Spain Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 49. Spain Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 50. Italy Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 51. Italy Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 52. Rest of Europe Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 53. Rest of Europe Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 54. Asia-Pacific Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 55. Asia-Pacific Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 56. Asia-Pacific Electrostatic Discharge (Esd) Packaging Market, by Country, 2021-2030,($Million)
Table 57. China Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 58. China Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 59. Japan Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 60. Japan Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 61. India Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 62. India Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 63. South Korea Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 64. South Korea Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 65. Australia Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 66. Australia Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 67. Rest of Asia-Pacific Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 68. Rest of Asia-Pacific Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 69. LAMEA Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 70. LAMEA Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 71. LAMEA Electrostatic Discharge (Esd) Packaging Market, by Country, 2021-2030,($Million)
Table 72. Brazil Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 73. Brazil Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 74. Saudi Arabia Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 75. Saudi Arabia Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 76. United Arab Emirates Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 77. United Arab Emirates Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 78. South Africa Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 79. South Africa Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 80. Rest of Latin America Electrostatic Discharge (Esd) Packaging Market, by Product Type, 2021-2030,($Million)
Table 81. Rest of Latin America Electrostatic Discharge (Esd) Packaging Market, by End-User, 2021-2030,($Million)
Table 82. Smurfit Kappa Group: Company Snapshot
Table 83. Smurfit Kappa Group: Operating Segments
Table 84. Smurfit Kappa Group: Product Portfolio
Table 85. Smurfit Kappa Group: Net Sales
Table 86. Smurfit Kappa Group: Key Stratergies
Table 87. Ppg Industries, Inc.: Company Snapshot
Table 88. Ppg Industries, Inc.: Operating Segments
Table 89. Ppg Industries, Inc.: Product Portfolio
Table 90. Ppg Industries, Inc.: Net Sales
Table 91. Ppg Industries, Inc.: Key Stratergies
Table 92. Tip Corporation: Company Snapshot
Table 93. Tip Corporation: Operating Segments
Table 94. Tip Corporation: Product Portfolio
Table 95. Tip Corporation: Net Sales
Table 96. Tip Corporation: Key Stratergies
Table 97. Conductive Containers Inc.: Company Snapshot
Table 98. Conductive Containers Inc.: Operating Segments
Table 99. Conductive Containers Inc.: Product Portfolio
Table 100. Conductive Containers Inc.: Net Sales
Table 101. Conductive Containers Inc.: Key Stratergies
Table 102. Elcom (Uk) Ltd.: Company Snapshot
Table 103. Elcom (Uk) Ltd.: Operating Segments
Table 104. Elcom (Uk) Ltd.: Product Portfolio
Table 105. Elcom (Uk) Ltd.: Net Sales
Table 106. Elcom (Uk) Ltd.: Key Stratergies
Table 107. Tandem Equipment Sales Inc.: Company Snapshot
Table 108. Tandem Equipment Sales Inc.: Operating Segments
Table 109. Tandem Equipment Sales Inc.: Product Portfolio
Table 110. Tandem Equipment Sales Inc.: Net Sales
Table 111. Tandem Equipment Sales Inc.: Key Stratergies
Table 112. Global Statclean Systems: Company Snapshot
Table 113. Global Statclean Systems: Operating Segments
Table 114. Global Statclean Systems: Product Portfolio
Table 115. Global Statclean Systems: Net Sales
Table 116. Global Statclean Systems: Key Stratergies
Table 117. Desco Industries: Company Snapshot
Table 118. Desco Industries: Operating Segments
Table 119. Desco Industries: Product Portfolio
Table 120. Desco Industries: Net Sales
Table 121. Desco Industries: Key Stratergies
Table 122. Dowdupont: Company Snapshot
Table 123. Dowdupont: Operating Segments
Table 124. Dowdupont: Product Portfolio
Table 125. Dowdupont: Net Sales
Table 126. Dowdupont: Key Stratergies
List of Figures
Figure 1. Hemostats Market Segmentation
Figure 2. Hemostats Market,2021-2031
Figure 3. Hemostats Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Hemostats Market:Drivers, Restraints and Opportunities
Figure 12. Hemostats Market,By Type,2021(%)
Figure 13. Comparative Share Analysis of Thrombin Based Hemostats Hemostats Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Oxidized Regenerated Cellulose Based Hemostats Hemostats Market,2021-2031(%)
Figure 15. Comparative Share Analysis of Combination Hemostats Hemostats Market,2021-2031(%)
Figure 16. Comparative Share Analysis of Gelatin Based Hemostats Hemostats Market,2021-2031(%)
Figure 17. Comparative Share Analysis of Collagen Based Hemostats Hemostats Market,2021-2031(%)
Figure 18. Comparative Share Analysis of Others Hemostats Market,2021-2031(%)
Figure 19. Hemostats Market,By Formulation,2021(%)
Figure 20. Comparative Share Analysis of Matrix and Gel Hemostats Hemostats Market,2021-2031(%)
Figure 21. Comparative Share Analysis of Sheet and Pad Hemostats Hemostats Market,2021-2031(%)
Figure 22. Comparative Share Analysis of Sponge Hemostats Hemostats Market,2021-2031(%)
Figure 23. Comparative Share Analysis of Powder Hemostats Hemostats Market,2021-2031(%)
Figure 24. Comparative Share Analysis of Others Hemostats Market,2021-2031(%)
Figure 25. Hemostats Market,By Application,2021(%)
Figure 26. Comparative Share Analysis of Orthopedic Surgery Hemostats Market,2021-2031(%)
Figure 27. Comparative Share Analysis of General Surgery Hemostats Market,2021-2031(%)
Figure 28. Comparative Share Analysis of Neurological Surgery Hemostats Market,2021-2031(%)
Figure 29. Comparative Share Analysis of Cardiovascular Surgery Hemostats Market,2021-2031(%)
Figure 30. Comparative Share Analysis of Reconstructive Surgery Hemostats Market,2021-2031(%)
Figure 31. Comparative Share Analysis of Gynecological Surgery Hemostats Market,2021-2031(%)
Figure 32. Comparative Share Analysis of Others Hemostats Market,2021-2031(%)
Figure 33. Hemostats Market by Region,2021
Figure 34. U.S. Hemostats Market,2021-2031($Million)
Figure 35. Canada Hemostats Market,2021-2031($Million)
Figure 36. Mexico Hemostats Market,2021-2031($Million)
Figure 37. Germany Hemostats Market,2021-2031($Million)
Figure 38. France Hemostats Market,2021-2031($Million)
Figure 39. U.K. Hemostats Market,2021-2031($Million)
Figure 40. Italy Hemostats Market,2021-2031($Million)
Figure 41. Spain Hemostats Market,2021-2031($Million)
Figure 42. Rest of Europe Hemostats Market,2021-2031($Million)
Figure 43. Japan Hemostats Market,2021-2031($Million)
Figure 44. China Hemostats Market,2021-2031($Million)
Figure 45. India Hemostats Market,2021-2031($Million)
Figure 46. Australia Hemostats Market,2021-2031($Million)
Figure 47. South Korea Hemostats Market,2021-2031($Million)
Figure 48. Rest of Asia-Pacific Hemostats Market,2021-2031($Million)
Figure 49. Brazil Hemostats Market,2021-2031($Million)
Figure 50. Saudi Arabia Hemostats Market,2021-2031($Million)
Figure 51. South Africa Hemostats Market,2021-2031($Million)
Figure 52. Rest of LAMEA Hemostats Market,2021-2031($Million)
Figure 53. Top Winning Strategies, by Year
Figure 54. Top Winning Strategies, by Development
Figure 55. Top Winning Strategies, by Company
Figure 56. Product Mapping of Top 10 Players
Figure 57. Competitive Dashboard
Figure 58. Competitive Heatmap of Top 10 Key Players
Figure 59. Baxter International Inc..: Net Sales ,($Million)
Figure 60. B.Braun Melsungen AG.: Net Sales ,($Million)
Figure 61. Becton Dickinson and Company.: Net Sales ,($Million)
Figure 62. Hemostatis LLC.: Net Sales ,($Million)
Figure 63. Integra Life Sciences Holding Corporation.: Net Sales ,($Million)
Figure 64. Johnson and Johnson.: Net Sales ,($Million)
Figure 65. Medtronic PLC.: Net Sales ,($Million)
Figure 66. Pfizer Inc..: Net Sales ,($Million)
Figure 67. Stryker Corporation.: Net Sales ,($Million)
Figure 68. Teleflex Incorporated.: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Hemostats Market," the hemostats market was valued at $2.8 billion in 2021, and is estimated to reach $4.7 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031.

Control of excessive bleeding during surgery is a difficult but important task. Products called hemostats can be placed on a bleeding sites during surgery to help the body’s own processes for clotting. It is used during early phases of surgery for an initial incision that closes blood vessels until ligation. Hemostats are look like rings scissors. Frequently hemostatic forceps have a locking mechanism called a ratchet, which is used for clamping. Hemostats such as absorbable gelatin sponge, collagen hemostat, and oxidized cellulose are commercially available.

Increase in number of product approvals notably contribute toward the growth of the global market. For instance, in July 2021, Baxter acquired PerClot Polysaccharide hemostatic system from CryoLife. This acquisition marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wide range of active and passive hemostatic solutions. In addition, in December 2020, Teleflex completed the acquisition of Z-Medica, LLC, an industry leading manufacturer of hemostatic products. Thus, rise in number of acquisitions boosts the growth of the hemostats market. In addition, surge in incidence of sports-related injuries spinal aliments is a key factor that fuels growth of the global market.

Moreover, according to study of BMJ Journals, in India, over 60,000 open heart surgeries are performed yearly. According to the report by the British Heart Foundation, in 2021, 7.6 million people were living with heart & circulatory diseases, and it causes about 25% deaths in the UK. Thus, alarming rise in the prevalence of cardiovascular diseases increases the number of cardiac surgeries, which lead to high usage of hemostats for performing surgeries is one of the leading hemostats market trends.

However, high cost of hemostat products hinder the growth of the market. On the contrary, advancements in hemostat products and increase in preference for surgeries are expected to offer remunerative opportunity for the manufacturers to tap and capitalize in the market.

The global hemostats market analysis is segmented into type, formulation, application, and region. By type, the market is categorized into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelation-based hemostats, collagen-based hemostats, and others.

On the basis of product type, the thrombin-based hemostats market size segment dominated the global market in 2021, and is anticipated to continue this trend during the forecast period, owing to surge in adoption of thrombin-based hemostats. In addition, the combination hemostats market share is expected to hold higher market share during the forecast period, owing to increase in investments in the development of new hemostat products and the advantages associated with the use of combination hemostats.

Depending on formulation, the matrix & gel hemostats market size acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period. This is attributed to the advantages associated with matrix & gel hemostats, such as easy application, biocompatibility, and cost-effectiveness. On the other, the hand sponge hemostats segment is expected to witness the highest growth in the market during forecast period.

By application, the orthopedic surgery segment dominated the market in 2021, and is anticipated to continue this trend during the forecast period. This is attributed to increase in number of cardiovascular diseases, which, in turn, has led to rise the number of cardiac surgeries.

Region wise, North America accounted for the largest share of the global hemostats industry in 2021, and is expected to remain dominant throughout the forecast period. This is attributed to the presence of giant biopharmaceutical and pharmaceutical firms in the U.S. In addition, increase in adoption of hemostats drives the hemostats industry growth in the region.

Key Findings of the Study

  • Depending on type, the thrombin-based hemostats segment held largest market share in 2021, and is expected to remain dominant throughout the forecast period.
  • By formulation, the matrix & gel hemostats dominated the global market in 2021, and is anticipated to continue this trend during the forecast period.
  • On the basis of application, the orthopedic surgery acquired the highest position in the global market, and is anticipated to continue this trend during the forecast period.
  • Region wise, North America is expected to experience notable growth, registering a CAGR of 4.3% during the forecast period.

Companies Mentioned

  • Baxter International Inc.
  • B.Braun Melsungen AG
  • Becton Dickinson and Company
  • Hemostatis LLC
  • Integra Life Sciences Holding Corporation
  • Johnson and Johnson
  • Medtronic plc
  • Pfizer Inc.
  • Stryker Corporation
  • Teleflex Incorporated

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information